In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to email@example.com.
Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice.
National Disease Surveillance Program—I. Case Reports—Revision—(NCID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Formal surveillance of 18 separate reportable diseases has been ongoing to meet the public demand and scientific interest in accurate, consistent, epidemiologic data. These ongoing disease reports include: Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob Disease (CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. Tularemia is a new addition to this submission. Case report forms from state and territorial health departments enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. This information is used to direct epidemiologic investigations, identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and develop guidelines for prevention and treatment. The data collected will also be used to recommend target areas most in need of vaccinations for selected diseases and to determine development of drug resistance.
Because of the distinct nature of each of the diseases, the number of cases reported annually is different for each. There is no cost to respondents other than their time.Start Printed Page 73007
|Form||Number of respondents||Number of responses per respondent||Total responses||Hrs/response||Total burden|
|Dengue Case Investigation||55||182||10,010||15/60||2,503|
|Hantavirus Pulmonary Syndrome||40||3||120||20/60||40|
|Legionellosis Case Report||23||11.7||269||20/60||90|
|Lyme Disease Report||52||261||20,020||5/60||1,668|
|Malaria Case Surveillance Report||55||20||1,100||15/60||275|
|Plague Case Investigation Report||55||0.20||11||20/60||4|
|Reye's Syndrome Case Surveillance Report||50||1||50||20/60||17|
|Tick-borne Rickettsial Disease Case Report||55||18||990||10/60||165|
|Trichinosis Surveillance Case Report||55||0.70||39||20/60||13|
|Typhoid Fever Surveillance Report||55||7||385||20/60||128|
|Viral Hepatitis Case Record||55||200||11,000||25/60||4,583|
Dated: December 2, 2005.
Acting Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E5-7038 Filed 12-7-05; 8:45 am]
BILLING CODE 4163-18-P